Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-25 @ 8:39 PM
Study NCT ID:
NCT01995669
Status:
COMPLETED
Last Update Posted:
2025-06-24
First Post:
2013-11-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-20
First Submit QC Date:
None
Study First Post Date:
2013-11-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-01-17
Results First Submit QC Date:
None
Results First Post Date:
2025-06-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-05
Last Update Post Date:
2025-06-24
Last Update Post Date Type:
ACTUAL